tiprankstipranks
Trending News
More News >
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market

Aspire Biopharma Holdings (ASBP) Financial Statements

Compare
138 Followers

Aspire Biopharma Holdings Financial Overview

Aspire Biopharma Holdings's market cap is currently $13.51M. The company's EPS TTM is $-1.564; its P/E ratio is -0.06; Aspire Biopharma Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Currency in USD

Aspire Biopharma Holdings Earnings and Revenue History

Aspire Biopharma Holdings Debt to Assets

Aspire Biopharma Holdings Cash Flow

Aspire Biopharma Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.